GlassScriptPhysician profile
Jeffrey T Waldrop
NPI 1396845616
$5,783.21
in general payments reported to CMS, 2019-2025
13 companies · $214 in 2025
The $214 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,938 · 2020: $67.82 · 2021: $1,796 · 2022: $292 · 2023: $243 · 2024: $233 · 2025: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $690.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $690.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,590.22 | 2019-2025 | Insignia, Mako, Triathlon |
| Pinnacle, INC | $1,215.36 | 2021-2025 | |
| Smith+Nephew, INC. | $533.95 | 2019-2021 | |
| Depuy Synthes Sales INC. | $243.71 | 2019-2025 | Na, Norian |
| Pacira Therapeutics, INC. | $59.38 | 2019 | |
| My01 INC. | $21.23 | 2022 | |
| Zimmer Biomet Holdings, INC. | $19.17 | 2024 | Tapestry |
| Linvatec Corporation | $19.10 | 2021 | |
| Orthofix Medical, INC. | $18.14 | 2020-2021 | |
| Heron Therapeutics, INC. | $17.75 | 2025 | Zynrelef |
| Integra Lifesciences Corporation | $17.19 | 2020 | |
| Medtronic USA, INC. | $14.68 | 2019 | |
| Vericel Corporation | $13.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Waldrop listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.